Oxford PharmaGenesis launches survey to understand the impact of content reuse permissions, restrictions and costs on the dissemination of medical research

Oxford PharmaGenesis is excited to announce the launch of a survey to capture the impact of content reuse permissions, restrictions and costs on the dissemination of medical research.

To help us understand your experiences, we invite any medical publications professionals who are involved in obtaining content reuse permissions from biomedical research journals to participate in this short (maximum 15-minute) survey.

Please share your experience with us here: https://forms.office.com/e/tRUgRZN9kS

Insights from this survey will be used to help continue the conversation with the pharma industry, as well as the medical communications and publishing communities, on the impact of content reuse permissions, restrictions and costs the dissemination of medical research.

Data collection is anonymous; respondents will not be identifiable. We will disseminate the survey findings at a future congress for publication professionals.

This survey closes on Monday 17 November 2025.

Privacy notice: This survey represents the work of Oxford PharmaGenesis. Data collected under this survey will be processed in accordance with Oxford PharmaGenesis’ privacy policy (https://www.pharmagenesis.com/privacy-and-security).

Please contact OpenPharmaSupport@pharmagenesis.com if you have any concerns or questions.